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Drug abuse has become a global issue of concern. It affects not only individual users, but
also their families and communities. Data were retrieved from the database of the Taiwan
Surveillance System of Drug Abuse and Addiction Treatment (SSDAAT) from 2002 to 2011,
and 147,660 cases reported by medical institutions in Taiwan were reviewed. This study
showed that the top five reported abused drugs by medical institutions during the last
decade were heroin, methamphetamine, benzodiazepines, ketamine, and zolpidem. Her-
oin and methamphetamine continued to be the first two abused drugs reported by medical
institutions. Heroin abuse was significant, but has shown a downward trend. However,
emerging abused drugs, such as ketamine and zolpidem, presented upward trends. 3,4-
Methylenedioxy-N-methylamphetamine (MDMA) abuse seems to have re-emerged and
has increased gradually since 2010. Injection without needle sharing has become the most
common route of administration of abused drugs since 2002. The majority of causes for
these reported drug abuses were drug dependence, followed by peer influence and stress
relief. Hepatitis C was the most commonly reported infectious disease, followed by hep-
atitis B and AIDS in the drug abusers reported by medical institutions. It should be noted
that access to drugs via the Internet increased year by year, and this is clearly an area
needing constant monitoring.
Copyright ª 2014, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.Open access under CC BY-NC-ND license. 1. Introduction
Drugs can cure people of diseases, however their misuse can
also generate crime, street violence, and other social problems
that harm societies. Drug abuse affects not only individual
users, but also their families and communities. In the USA,
there were 5.1 million drug-related emergency departmentinistration, Ministry of
. Tsay).
ministration, Taiwan. Publi(ED) visits in 2011; about a half (49%) were attributed to drug
misuse or abuse with 45% attributed to adverse drug re-
actions. ED visits involving use of illicit drugs increased from
2009 (974,392 visits) to 2011 (1,252,500 visits); the rate of visits
involving illicit stimulants increased by 68%. ED visits
involving misuse or abuse of pharmaceuticals increased from
2004 (626,470 visits) through 2011 (1,428,145 visits); the mostHealth and Welfare, Number 161-2, Kuen Yang Street, Nangang
shed by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license. 
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medications and narcotic pain relievers (160.9 visits and 134.8
visits per 100,000 population, respectively) [1]. The United
Nations Office on Drugs and Crime (UNODC) estimated in 2010
that 10e13% of drug users continued to be problem users with
drug dependence and/or drug use disorders, the prevalence of
human immunodeficiency virus (HIV), hepatitis C virus (HCV),
and hepatitis B virus (HBV) among injecting drug users
continuing to add to the global burden of disease, and
approximately one in every 100 deaths among adults was
attributed to illicit drug use [2].
According to the Atlas on Substance Use 2010 of the World
Health Organization (WHO) [3], global prevalence rates of
drug use disorders were estimated to range from 0% to 3%,
with the highest prevalence rates found in the Eastern
Mediterranean region. In the estimated annual prevalence of
illicit drug use in 2010, cannabis remained the world’s most
widely used illicit substance, ranging from 2.6% to 5% of the
adult population (119e224 million estimated users aged
15e64 years). Amphetamine-type stimulants (ATS) (excluding
“ecstasy”) remained second with an estimated prevalence of
0.3e1.2% (14.3e52.5 million users), and opioid (mainly heroin,
morphine, and nonmedical use of prescription opioids) was
placed third at 0.6e0.8% of the population aged 15e64 years
(26.4e36 million opioid users) [2]. Besides, there were
99,000e253,000 deaths globally in 2010 as a result of illicit
drug use, with drug-related deaths accounting for 0.5e1.3% of
all-cause mortality among those aged 15e64 years, which
was taken as 18.74 million [4]. Heroin, cocaine, and other
drugs kill around 0.2 million people each year, shattering
families and bringing misery to thousands of other people.
Drug abuse not only undermines economic and social
development, but also contributes to crime, instability, inse-
curity, spread of diseases, and considerable costs to health
care services [2,5e8].
In Taiwan, approximately 1.43% of persons aged 12 years to
64 years (252 thousand people) abused drugs at least once in
2009 [9]. Our study was designed specifically to address the
trend of drug abuse from 2002 through 2011 by analyzing the
drug abuse data reported by medical institutions from the
Surveillance System of Drug Abuse and Addiction Treatment
(SSDAAT), which was established by the National Bureau of
Controlled Drugs, Department of Health in 1995. The National
Bureau of Controlled Drugs was mandated to merge into the
Taiwan Food and Drug Administration, Department of Health
in 2010. Drug abuse cases have been reported online since
2002 [10e12].2. Methods
2.1. Data sources
The data for this study were derived from the SSDAAT. To
date, there are a total of 598 medical institutions, which have
enrolled SSDAAT as reporters, in Taiwan. The cases with drug
abuse problems were reported by filling out the drug abuse
case reporting sheet via the Internet. From 2002 to 2011,
147,660 cases reported by medical institutions on the SSDAAT
were reviewed.2.2. Measures
In order to know the real time information of drug abuse in
Taiwan, the National Bureau of Controlled Drugs, psychiatric
hospitals, and specialists in drug abuse-related fields in
Taiwan codesigned the drug abuse case reporting sheet for
medical institutions to report the cases that were diagnosed
with drug abuse problems. The reporting sheet contained 20
questions with items on demographic characteristics, age of
first drug use, reasons for seeing a doctor, motives for drug
use, drug use history, the routes of administration, the places
of drug abuse, and the types of drug used.
2.3. Statistical analysis
All analyses were performed in SPSS for Windows Version
17.0 (SPSS Inc., Chicago, IL, USA). For statistical analysis, either
c2 or one sample t test was used for comparison, as appro-
priate, and a p value of 0.05 was used as the criterion of sig-
nificance. Microsoft Office Excel 2010 (Microsoft Corporation,
Redmond, WA, USA) was used in this study to construct the
charts to present the changes of each variable for each year.
2.4. Study restrictions
The SSDAAT is a reporting system that, without the use of
coercion, encourages medical institutions to voluntarily
report drug abuse cases. Although 598 medical institutions
(over a half) have enrolled in the SSDAAT as reporters in
Taiwan, not all psychiatric institutions have been involved,
therefore not every drug abuse case has been reported to the
SSDAAT.
Considering patients’ privacy, the willingness of medical
institutions to report cases, and the Personal Data Protection
Act, only basic demographic characteristics such as gender,
age, education, marriage, reason for seeing doctors, and drug
use history were queried in each case. Hence, it was difficult
for the data in the SSDAAT to combine with other drug- and
health-related research databases, such as the National
Health Insurance and National Health Interview, for obtaining
more information on drug abusers.3. Results and discussion
3.1. Demographic data
On analyzing the data of 147,660 reported cases over the years,
males outnumbered females by a factor of 6.1 in 2002, reduced
to 4.9 in 2011, and then there was an upward trend in the
number of female cases. Demographic data of reported re-
cords are shown in Table 1.While illicit drug use amongmales
in general greatly exceeded that among females, the
nonmedical use of tranquillizers and sedatives among fe-
males in South America, Central America, and Europe is a
notable exception to the rule [2].
The highest estimated prevalence rates of drug use disor-
ders among men (1.6%) and women (0.4%) were found in
parts of the Americas. Selected countries in Africa, Eastern
Mediterranean, Europe, and theWestern Pacific were found to
Table 1 e Demographic data of the drug abuse cases reported by medical institutions during the period 2002e2011.
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
Gender**
Male 86.0 86.0 84.3 84.1 82.6 83.4 83.2 83.1 83.3 83.0
Female 14.0 14.0 15.7 15.9 17.4 16.6 16.8 16.9 16.7 17.0
Male/female ratio 6.1 6.2 5.4 5.3 4.8 5.0 5.0 4.9 5.0 4.9
Age (y)**
Under 20 3.0 1.7 1.1 0.8 0.4 0.3 0.3 0.4 0.3 1.2
20e29 43.1 39.4 37.2 32.3 26.7 23.3 18.2 15.0 12.4 13.2
30e39 37.6 39.5 40.8 42.4 41.3 43.9 45.7 45.8 45.1 41.9
40e49 13.7 16.8 17.1 19.7 24.7 25.2 27.3 29.5 31.9 31.0
>50 2.5 2.6 3.6 4.7 7.0 7.2 8.4 9.2 10.2 12.7
Mean age of first drug use (y)* 24.7 25.0 25.6 26.1 26.9 26.4 26.4 26.1 26.5 26.7
Education**
Elementary school and below 6.6 6.1 6.0 6.7 6.9 7.5 7.6 7.6 8.0 8.5
Junior high school 47.8 48.1 46.4 46.3 44.6 46.8 47.9 47.8 47.8 49.4
Senior high/vocational school 40.6 41.8 42.9 42.6 44.1 41 39.9 39.6 39.3 37.0
College and above 4.2 2.9 3.1 3.4 3.5 3.8 4.0 4.0 4.1 4.2
Others 0.8 1.0 1.6 0.9 0.9 0.9 0.6 1.0 0.8 0.9
Marriage**
Single 54.1 51.4 50.2 51.7 49.1 50.9 51.5 51.4 51.3 52.0
Married 33.1 35.1 36.9 35.7 35.6 30.6 27.8 28.0 26.5 26.6
Divorced 10 10.7 10.1 11.2 13.1 16.5 18.1 17.8 19.3 19.2
Widow/widower 0.6 1.0 1.2 0.5 0.9 0.6 0.5 0.5 0.7 0.6
Others 2.1 1.7 1.6 0.8 1.3 1.4 2.0 2.3 2.1 1.5
Reason for seeing doctor**
Drug dependence 58.6 79.2 91.2 90.7 90.1 85.2 83.5 86.8 88.6 83.1
Mental illness 5.2 5.9 4.4 4.3 3.3 3.3 2.1 1.7 2.0 1.7
Drug overdose 10.1 1.1 1.4 1.1 2.0 2.5 2.4 2.1 1.9 2.9
Corrective 10.6 3.0 0.2 2.4 1.4 0.5 0.1 0.1 0.1 0.3
Others 15.5 10.8 2.4 1.5 3.2 8.4 11.9 9.4 7.3 12.0
Drug use history**
<1 y 14.7 8.7 5.8 5.5 6.7 6.8 3.9 3.1 3.6 6.5
1e5 y 43.0 44.1 43.2 42.0 38.9 28.9 24.3 18.3 18.8 20.4
6e10 y 24.4 21.6 21.3 22.0 24.7 24.5 24.6 22.7 24.1 20.3
>10 y 17.9 25.6 29.7 30.5 29.7 39.8 47.1 55.9 53.5 52.8
Data are presented as percentages unless indicated otherwise.
* One sample t test: p < 0.001.
** c2 test: p < 0.001.
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[3]. The mean age of first drug use (ranging from 0 years to 70
years) on the SSDAAT from 2002 to 2011 was 24.7 years in 2002
and the peak was 26.9 years in 2006. In terms of age distri-
bution, most were between 30 years and 39 years (37.6% in
2002 and 41.9% in 2011, the peak of 45.8% in 2009). The 20e29
year age group has declined and the 40e49 year age group has
increased every year since 2002, except 2011. The percentage
for the “50 years and over” age group has increased every year
from 2002. Most of the reported cases fell within the age
groups of 20e29 years, 30e39 years, and 40e49 years.
Regarding educational level, themajority were “junior high
school” (47.8% in 2002 and 49.4% in 2011, the valley 44.6% in
2006) followed by “senior high/vocational school” (40.6% in
2002 and 37.0% in 2011, the peak 44.1% in 2006); however,
“elementary school and below” and “college and above” have
presented upward trends since 2004 and 2003, respectively, as
shown in Table 1.
In terms of marriage, most of the reported cases (about a
half) were single; the proportion of “married” cases increased
from 33% in 2002 to 36.9% in 2004, but declined from 35.7% in
2005 to 26.6% in 2011. By contrast, the proportion of “divorced”cases increased from 10% in 2002 to 19.2% in 2011. As for the
reason for seeing a doctor, the major reason was drug
dependence (79.2% in 2003, 83.1% in 2011, and the peak 91.4%
in 2004), followed by drug overdose (1.1% in 2003 and 2.9% in
2011) and mental illness (5.9% in 2003 and 1.7% in 2011).
The findings of this study indicate that drug abuse among
males greatly exceeded that among females. However, the
differences were reduced and drug abuse cases among fe-
males have increased over the years. Although the data ob-
tained from drug abuse cases reported bymedical institutions
may not reflect the real drug abuse situation, these are
consistent with the results of the 2005 and 2009 National
Health Interview and Drug Abuse Surveys [9,13].
3.2. Most commonly abused drugs
The most commonly abused drugs in the cases reported
by medical institutions in Taiwan were heroin, metham-
phetamine, benzodiazepines, ketamine, zolpidem, and 3,4-
methylenedioxy-N-methylamphetamine (MDMA). Heroin
use increased in 2002 and 2003, the growth curve remained
stagnant from 2004 to 2007 (93.8%), and then it declined (83.3%
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able climb from 2003 onwards and then it fell in 2008. The use
of benzodiazepines (5.4% in 2002 and 2.5% in 2011, the peak
7.3% in 2006) presented a downward trend. Both ketamine and
zolpidem use have increased yearly since 2002 and showed
upward trends as well. MDMA use decreased from 2002 (3.3%)
to 2009 (0.3%) and then increased over consecutive years (1.7%
in 2011), as shown in Fig. 1.
Heroin and methamphetamine have been categorized as
Schedule I and II controlled drugs, respectively, in many
countries including Taiwan [14,15] on consideration of their
high addiction, abuse levels, tolerance, and harm to society.
They are traditionally abused in Taiwan. To date, heroin and
methamphetamine have continued to be the two commonly
abused drugs reported by medical institutions in Taiwan. The
abuse of these two drugs is still serious, but heroin use has
shown a downward trend. By contrast, emerging drugs of
abuse such as ketamine, zolpidem, and MDMA have pre-
sented upward trends (Fig. 1).
In Taiwan, methamphetamine is the second abused drug
of concern and its appearance is mainly crystalline. In
Southeast Asia, crystal methamphetamine is the most
commonly used drug in Brunei Darussalam, Japan,
Philippines, and the Republic of Korea. In China, opioids
(mainly heroin) are the primary drug of concern, followed by
ATS and tranquilizers [2]. More than half of the United
Nations (UN) Member States have reported ATS-related
manufacturing since 1990. In 2009, 10,598 ATS laboratories
were dismantleddmostly methamphetamine (96%), followed
by combined ATS (3%) [16].
Ketamine, a Schedule III controlled drug in Taiwan, is a
derivative of phencyclidine that possesses anesthetic and
analgesic effects. The control of ketamine is less tight thanFig. 1 e The trends for the most commonly abused drugs repor
* % [ the percentage of cases reported. MDMA [ 3,4-methylenthose of Schedule I and II drugs such as heroin, metham-
phetamine, and MDMA. Therefore, it is sometimes mistaken
that ketamine abuse may not undermine one’s health. Due to
its dissociative and paralytic effects, ease of availability, and
low cost, ketamine has gained popularity among Taiwan’s
young people and has become the most commonly abused
drug of choice for recreation in pubs. According to the statis-
tics of drug abuse cases and laboratory testings, the amounts
of yearly ketamine seizures by judicial systems increased
from 9.5 kg in 2002 to 1371.9 kg in 2011 and have ranked the
highest since 2006 [17].
Although ketamine has not been scheduled by the UN, the
trend of ketamine abuse has been alarming worldwide. In
Southeast Asia, the abuse trend of ketamine is on the rise. In
China (including Hong Kong), Malaysia, and Vietnam, keta-
mine use was also perceived to increase in 2010 [2]. Ketamine
not only causes long-term adverse health effects in recrea-
tional users, including tolerance, dependence, and bladder
syndrome [18e21], but also a number of drug-related prob-
lems such as considerable costs to health care services.
In Taiwan, ketamine abuse is serious and its danger is
noticed by the authorities. The incumbent agencies have
started to revise the law to enhance the penalties of
manufacturing and selling Schedule III drugs. However, the
incumbent agencies have not reached a consensus to
reschedule ketamine. It is recommended that the assessment
system for drug scheduling should take not only the addiction
potentials, but also the levels of abuse and facts on social
harm into consideration. In addition, it is necessary to enforce
drug abuse prevention and education. Incumbent agencies
and nongovernmental organizations (NGOs) should work
closely and campaign to enhance perception and alertness on
the hazards of drug abuse among the public.ted by medical institutions in Taiwan from 2002 to 2011.
edioxy-N-methylamphetamine.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 2 ( 2 0 1 4 ) 1 6 9e1 7 7 173On further analysis of the data by age, flunitrazepam (FM2)
was found to be the major abused drug of the benzodiazepine
family; it was especially popular among persons aged 40 years
and over andwas ranked the third reported abused drug in this
age group within the period 2002e2007. Zolpidem is one of the
nonbenzodiazepine hypnotics (z-drugs), with effects similar to
benzodiazepines, and it was also found to be popular among
persons aged 40 years and over; it was ranked as the third re-
ported abused drug in this age group since 2008. Benzodiaze-
pines and z-drugs are psychoactive drugs and are useful in the
treatment of insomnia and anxiety [22e24]. They are pre-
scriptiondrugs and categorized as Schedule IV controlleddrugs
by the International Narcotics Control Board (INCB), except for
FM2, which is a Schedule III drug under the Convention on
Psychotropic Substances [25]. The abuse of FM2 and zolpidem
implies an existing and growing problem of abuse of prescrip-
tion drugs for nonmedical purposes in Taiwan.
The nonmedical use of prescription drugs, including tran-
quillizers and sedatives, is reported to be significantly
increased and poses a growing health problem in a number of
developed and developing countries [2,26e28]. The report of
the INCB for 2006 highlighted that prescription drugs have
become the second most abused class of drugs after cannabis
in the United States [26]. According to results from the 2010
National Survey on Drug Use and Health (NSDUH), an esti-
mated 2.4 million Americans used prescription drugs non-
medically for the first time within the past year. More than a
half were females and about a third were aged 12e17 years
[29]. In Australia, there was also a statistically significant in-
crease in the use of pharmaceuticals for nonmedical purposes
among persons aged 14 years and over [28].
MDMA, the best known member of the ‘ecstasy’ com-
pounds [MDMA, 3,4-methylenedioxyamphetamine (MDA),
methylenedioxyethylamphetamine (MDE), etc.] is making a
comeback. An increase in the purity of ecstasy available in
Europewas pointed out in the EuropeanMonitoring Centre for
Drugs and Drug Addition (EMCDDA) 2012 annual report [30].
European studies show higher prevalence of ecstasy use
among club goers in comparison with such use among the
general population [31,32]. In Australia, ecstasy among Aus-
tralia’s regular drug users in pubs, clubs, and music festivals
appears to resurge, and the number of ecstasy users taking
synthetic drugs such as emerging psychoactive substances
has increased [33]. The finding in this study also shows the
percentage of MDMA use reported from medical institutions
in Taiwan has obviously risen from 0.3% in 2009 to 1.7% in
2011. This indicates that the abuse of MDMA in Taiwan has
synchronized with Europe, Australia, and the United States.
Illicit use of Schedule I and II drugs is an indictable criminal
offense in Taiwan. It can cause liability in peoplewhouse drugs
with low dependence without proactively seeking treatment. It
is not sufficient to assess trends or situations of drug abuse by
simply analyzing one database of a surveillance system. The
drugabusedata inthis studymaynotrepresent the real scenario
in the whole drug abuse population in Taiwan. Therefore, in
order to represent the drug abuse situation in Taiwan, it is
necessary to compile information on other reporting systems
such as the Analytic Laboratory Drug Abuse Report System
(ALDARS), which gathers nationwide identification of cases
including urine and nonurine samples, the reporting system ofillegal drugs seized from the Ministry of Justice, the reporting
system of illegal drug-related charges from the Ministry of the
Interior, the reporting subsystem of HIV/AIDS from the Center
for Diseases Control, Ministry of Health and Welfare, and the
NationalHouseholdSurveyonDrugAbuse inTaiwan[10e12,34].
3.3. The causes of drug abuse, common sources of
abused drugs, and places of common access to drugs
Themajor causesof drugabuseweredrugdependence (23.2% in
2002 and 47% in 2011, the peak 52% in 2009), followed by peer
group influence (16.7% in2011, thepeak28.3% in2004)andstress
relief (14.1% in 2011, the peak 21.6% in 2004) as shown in Fig. 2.
It was globally estimated that 153e300 million people aged
15e64 years (3.4e6.6% of the world’s population in that age
group) have used an illicit substance at least once in 2010.
Problem drug users are estimated to number approximately
15.5e38.6 million (almost 12% of illicit drug users), including
those with drug dependence, and drug use disorders remain a
particular concern [2].
In terms of common sources of abused drugs, the drugs
were mostly sourced from drug dealers (58.3% in 2003 and
52.8% in 2011), followed by peers (35.6% in 2003 and 37.3% in
2011) and doctor/pharmacist (2.5% in 2003, 5.3% in 2011, with a
peak of 6.7% in 2008), as shown in Fig. 3.
The top three common places of access to drugs were the
shops for KARAOK singing which have air bands and televi-
sion screens (KTV)/the shops for watching music videos and
movie DVD/tapes (MTV)/Internet cafes, video arcades/game
parlors, and disco pubs/night clubs/bars.
It should be noted that the percentage of access to drugs
from the Internet has increased year by year (0.1% in 2003, the
peak 0.7% in 2011). The National Drug and Alcohol Research
Centre in Australia also identified the emergence of the
Internet as a major retailer of illicit drugs and “legal highs” in
creating a paradigm shift in drug use globally [35]. This is
clearly an area that requires monitoring.
Risk factors for drug dependence may differ among coun-
tries. However, Degenhardt et al [36] pointed out a range of
variables that were common to the development of illicit drug
dependence among users: early onset of drug use, using more
types of illicit drugs, and onset of externalizing (e.g., conduct
disorder) or internalizing mental disorders (e.g., depression)
before the age of 15 years [36].
3.4. The routes of administration
There are many routes of administration, including oral
ingestion, injectioneneedle sharing, injectionenon-needle
sharing, smoking, snorting, sniffing, and inhaling. Injection
without needle sharing (50.4% in 2002 and 65.2% in 2011, the
peak 69.9% in 2010) has become the main route of adminis-
tration reported since 2002. In comparison with the percent-
age of injectioneneedle sharing, which showed growth after
2002 but declined from 2005 to 2011, that of injectionenon-
needle sharing increased in the period 2005e2010 as shown in
Fig. 4.
The major route of administration for heroin was injec-
tionenon-needle sharing, followed by smoking and injec-
tioneneedle sharing. With regard to methamphetamine, the
Fig. 2 e The trends for causes of drug abuse reported by medical institutions in Taiwan from 2002 to 2011.* Others include
disease treatment, suicide, weight loss, and nonmentioned reasons.
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common route was injectionenon-needle sharing. As for ke-
tamine, snorting was themain route, oral was the second, and
smoking was the third. Oral was the major route for both
MDMA and benzodiazepines.
Drug use by injection is an extreme form of illicit drug use
withserioushealth implicationsandcosts for the individualand
thecommunity.Mathersetal [37]pointedout that injectingdrug
users account for about 7.5% of all drug users worldwide and
there were approximately 15.9million (range 11.0e21.2million)
injecting drug users in the world, with the largest numbers in
China, the United States, and the Russian Federation.
In 2005, Taiwan introduced the national harm reduction
program, which included the methadone maintenanceFig. 3 e The trends for common sources of abused drugs repotreatment program and the needle exchange program (NEP),
to reduce the harm associated with using unsterile or
contaminated injecting equipment and the spread of HIV
among injecting drug users (IDUs). The findings of this study
suggest that the percentage of cases of injectioneneedle
sharing has been in decline since 2005 and indicates that HIV
spread among IDUs has been effectively curbed; therefore, the
NEP seems to have brought about positive effects.
3.5. Health problems of drug abusers
From these drug abuse data reported by the medical in-
stitutions in Taiwan, we found hepatitis C is the most
commonly reported infectious disease, followed by hepatitis Brted by medical institutions in Taiwan from 2002 to 2011.
Fig. 4 e The trends for routes of administration in drug abuse reported by medical institutions in Taiwan from 2002 to 2011.
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2011, the valley 4.3% in 2005) has been a remarkable climb
from 2006 to 2008 and presented an upward trend. The re-
ported AIDS cases (0% in 2002e2003 and 0.1% in 2004, the peak
10.1% in 2010) increased from 2004 to 2010 and the growth
curve had a little decline in 2011 (8.7%). It needs to be noted
that the percentage of syphilis increased in the periodFig. 5 e The trends for health problems in drug abusers repor2002e2011 (0% in 2002, the peak 0.8% in 2010 and 0.6% in 2011)
as shown in Fig. 5.
Drug use by injection was significantly associated with the
transmissions of HCV, HBV, and HIV, which was similar to
many studies reported [38e40]. Research indicated that the
prevalence of HCV among groups of IDUs ranged from 30% to
98% [38e40]. Despite the existingdatahavingmany limitations,ted by medical institutions in Taiwan from 2002 to 2011.
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diseases remained one of the health consequences among
drugabusers.Druguseby injection isan important causeofHIV
transmission in most countries. Mathers et al [37] estimated
that about 3.0 million (range 0.8e6.6 million) people worldwide
who inject drugs might be HIV positive.
In Taiwan, the response to blood-borne virus transmission
among IDUs has primarily focused on HIV. Maintaining and
strengthening the response to HIV among IDUs remains
crucial, however, the significance of viral hepatitis must
receive greater recognition than it does at the present
moment. Investment in and development of comprehensive
and effective strategies to prevent the transmission of viral
hepatitis, and reduce resultant morbidity and mortality
among IDUs, are urgently required.4. Conclusions
The drug abuse problem has been one of the toughest issues
for governments around the world. Risky injecting and sexual
behavior among drug users are major public health concerns
because of the high risk for the transmission of blood-borne
infections such as HIV, HCV, and HBV, especially among the
marginalized and most at risk populations.
In Taiwan, traditionally abused drugs like heroin and
methamphetamine continue to be the top two abused drugs
reported by medical institutions. By contrast, users of
emerging drugs such as ketamine have increased gradually
over the years and the abuse of MDMA has seen a resurgence.Conflicts of interest
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